Changes in amyloidosis phenotype over 11 years in a cardiac amyloidosis referral centre cohort in France
Archives of Cardiovascular Diseases · 2023
DOI: 10.1016/j.acvd.2023.07.003 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Archives of Cardiovascular Diseases, 2023. Verfasst von Thibaud Damy und 37 weiteren Autor:innen. Beteiligte Einrichtung: French Referral Centre for Cardiac Amyloidosis, GRC Amyloid Research Institute, Amyloidosis Mondor Network, all at Henri-Mondor Teaching Hospital, AP…. Hauptthemen laut MEDLINE: Referral and Consultation, Cardiomyopathies, Amyloid Neuropathies, Familial, Immunoglobulin Light-chain Amyloidosis. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 64 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Early cardiac amyloidosis (CA) diagnosis enables patients to access effective treatments for better long-term outcomes, yet it remains under-recognised, misdiagnosed and inadequately managed. AIM: To reduce diagnostic delays, we aimed to describe the epidemiological and clinical characteristics and changes over an 11-year period. METHODS: This was a retrospective, observational cohort study of all patients referred to the Henri-Mondor Hospital for suspected CA. RESULTS: Overall, 3194 patients were identified and 3022 were included and analysed. Our patients came from varied ethnic backgrounds, and more than half (55.2%) had confirmed CA. Over 11 years, referrals increased 4.4-fold, mostly from cardiologists. Notably, wild-type transthyretin amyloidosis (ATTRwt) became the predominant diagnosis, with referrals increasing 15-fold from 20 in 2010-2012 to 308 in 2019-2020. The number of amyloid light chain (AL) diagnoses increased, whilst variant transthyretin amyloidosis (ATTRv) numbers remained relatively stable. Concerning disease severity, AL patients presented more frequently with severe cardiac involvement whereas an increasing number of ATTRwt patients presented with National Amyloid Centre stage I (22.0% in 2013-2014 to 45.9% in 2019-2020). Lastly, among patients diagnosed with ATTRv in 2019-2020, 83.9% had ATTR Val122Ile cardiac phenotype. CONCLUSIONS: This study shows that increasing cardiologist awareness and referrals have increased CA diagnoses. With improved awareness and non-invasive diagnostic techniques, more patients with ATTRwt with milder disease and more ATTRv Val122Ile mutations are being referred and diagnosed. Although more AL cases are being recognised, patients are diagnosed with severe cardiac involvement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- French Referral Centre for Cardiac Amyloidosis, GRC Amyloid Research Institute, Amyloidosis Mondor Network, all at Henri-Mondor Teaching Hospital, AP-HP, 94010 Creteil, France; Cardiology department, Henri-Mondor Teachi…
- French Referral Centre for Cardiac Amyloidosis, GRC Amyloid Research Institute, Amyloidosis Mondor Network, all at Henri-Mondor Teaching Hospital, AP-HP, 94010 Creteil, France; Université Paris Est Creteil, Inserm, IMRB…
- French Referral Centre for Cardiac Amyloidosis, GRC Amyloid Research Institute, Amyloidosis Mondor Network, all at Henri-Mondor Teaching Hospital, AP-HP, 94010 Creteil, France; Nephrology department, Henri-Mondor Teachi…
- Genetic Department, Henri-Mondor Teaching Hospital, 94010 Creteil, France; Pathology department, Henri-Mondor Teaching Hospital, 94010 Creteil, France.
- Clinical Epidemiology and Ageing (CEpiA) Geriatrics, Primary Care and Public Health, 94010 Créteil, France; Université Paris Est Creteil, Inserm, IMRB, 94010 Creteil, France.
- French Referral Centre for Cardiac Amyloidosis, GRC Amyloid Research Institute, Amyloidosis Mondor Network, all at Henri-Mondor Teaching Hospital, AP-HP, 94010 Creteil, France; DMU care, Henri Mondor Teaching Hospital,…
Zitieren
APA
Damy, T., Zaroui, A., de Tournemire, M., Kharoubi, M., Gounot, R., Galat, A., Guendouz, S., Funalot, B., Itti, E., Roulin, L., Audard, V., Fanen, P., Leroy, V., Poulot, E., Belhadj, K., Mallet, S., Deep Singh Chadah, G., Planté-Bordeneuve, V., Gendre, T., …, & Teiger, E. (2023). Changes in amyloidosis phenotype over 11 years in a cardiac amyloidosis referral centre cohort in France. Archives of Cardiovascular Diseases. https://doi.org/10.1016/j.acvd.2023.07.003
Vancouver
Damy T, Zaroui A, de Tournemire M, Kharoubi M, Gounot R, Galat A, et al. Changes in amyloidosis phenotype over 11 years in a cardiac amyloidosis referral centre cohort in France. Archives of Cardiovascular Diseases. 2023. doi:10.1016/j.acvd.2023.07.003
BibTeX
@article{Damy2023,
author = {Damy, Thibaud and Zaroui, Amira and de Tournemire, Marie and Kharoubi, Mounira and Gounot, Romain and Galat, Arnault and Guendouz, Soulef and Funalot, Benoit and Itti, Emmanuel and Roulin, Louise and Audard, Vincent and Fanen, Pascale and Leroy, Vincent and Poulot, Elsa and Belhadj, Karim and Mallet, Sophie and Deep Singh Chadah, Gagan and Planté-Bordeneuve, Violaine and Gendre, Thierry and Chevalier, Xavier and Guignard, Sandra and Bequignon, Emilie and Bartier, Sophie and Folliguet, Thierry and Lemonier, François and Audureau, Etienne and Tixier, Denis and Canoui-Poitrine, Florence and Lefaucheur, Jean-Pascal and Souvannanorath, Sarah and Authier, Francois-Jerome and Maupou, Steven and Hittinger, Luc and Molinier-Frenkel, Valérie and David, Jean-Philippe and Broussier, Amaury and Oghina, Silvia and Teiger, Emmanuel},
title = {Changes in amyloidosis phenotype over 11 years in a cardiac amyloidosis referral centre cohort in France},
journal = {Archives of Cardiovascular Diseases},
year = {2023},
doi = {10.1016/j.acvd.2023.07.003}
}
EUVIMED